(Q41117168)

reason for preferred rank

27 September 2017

title

Oral adjuvant therapy in breast carcinoma—a multicentre trial (English)

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(79)80020-1

27 June 2022

Oral adjuvant therapy in breast carcinoma--a multicentre trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A387233

multicenter clinical trial

27 June 2022

main subject

0 references

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(79)80020-1

27 June 2022

author name string

D. P. Leiberman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A387233

27 June 2022

D. A. Berstock

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A387233

27 June 2022

J. Houghton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A387233

27 June 2022

G. Kearney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A387233

27 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=387233

27 June 2022

publication date

1 June 1979

1 reference

full work available at URL

27 September 2017

https://api.elsevier.com/content/article/PII:S0305737279800201?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(79)80020-1

https://api.elsevier.com/content/article/PII:S0305737279800201?httpAccept=text/plain

27 June 2022

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(79)80020-1

27 June 2022

published in

Cancer Treatment Reviews

1 reference

27 September 2017

volume

6 Suppl

1 reference

27 September 2017

page(s)

91-96

1 reference

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980020-1

7 January 2021

Status of adjuvant therapy: results of The National Surgical Adjuvant Breast Project studies on oophorectomy, postoperative radiation therapy, and chemotherapy. Other comments concerning clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980020-1

7 January 2021

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980020-1

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980020-1

7 January 2021

Cancer Treatment Reports

7

author name string

Salaman

publication date

1979

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(79)80020-1

17 April 2023

Identifiers

1 reference

27 September 2017

1 reference